Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Core Points - Aethlon Medical, Inc. announced a public offering of 5,000,000 shares of common stock and warrants to purchase an additional 5,000,000 shares at a price of $0.90 per share [1] - The gross proceeds from the offering are expected to be approximately $4.5 million, which will be used for general corporate purposes including clinical trial expenses and research and development [2] Company Overview - Aethlon Medical, Inc. is a clinical-stage medical device company based in San Diego, California, focused on developing the Hemopurifier to address needs in oncology and infectious diseases [5]